- In latest TV spat, Fox News blocked from Dish Network
Associated Press, Sunday - 12/21/2014 - 01:26 PM
Dish Network subscribers were unable to watch Fox News Channel and the Fox Business Network on Sunday when the channels were taken down as part of contract negotiations.
- Gulf stocks climb with Dubai gaining 9.9 percent
Associated Press, Sunday - 12/21/2014 - 12:04 PM
Gulf stocks have opened the week with a climb that saw Dubai's main index gaining 9.9 percent.
- Rising anger as Nicaragua canal to break ground
Associated Press, Sunday - 12/21/2014 - 09:31 AM
As a conscripted soldier during the Contra War of the 1980s, Esteban Ruiz used to flee from battles because he didn't want to have to kill anyone. But now, as the 47-year-old farmer prepares to fight for his land, Ruiz insists, "I'm not going to run."
- Greek prime minister open to 2015 early elections
Associated Press, Sunday - 12/21/2014 - 08:51 AM
Greece's prime minister says early general elections could be called by the end of 2015 if the current legislature can elect a president and if negotiations with the country's creditors on post-bailout aid are completed.
- Tourism suffers in winter of EU-Russia discontent
Associated Press, Sunday - 12/21/2014 - 06:29 AM
Russia's tensions with the West over Ukraine and the slump for the ruble are echoing through the French Alps - and unfortunately for some businesses, just in time for ski season.
- AP source: US seeks China's help after cyberattack
Daily Oklahoman, Saturday - 12/20/2014 - 06:02 PM
The United States is asking China for help as it weighs potential responses to a cyberattack against Sony Pictures Entertainment that the U. S. has blamed on North Korea. A senior Obama administration official says the U. S. and China have shared information about the attack and that the U. S.
- N. Korea proposes joint probe over Sony hacking
Miami Herald, Saturday - 12/20/2014 - 08:49 AM
North Korea on Saturday proposed a joint investigation with the U. S. into the hacking attack against Sony Pictures Entertainment, warning of "serious" consequences if Washington rejects a probe that it believes will prove Pyongyang had nothing to do with the cyberattack. …
- Ruble crisis threatens Kontinental Hockey League
Daily Oklahoman, Saturday - 12/20/2014 - 07:07 AM
The Russia-based Kontinental Hockey League saw itself as the oil-rich rival to the NHL, offering a tempting, if less prestigious, alternative to playing in North America. As the league planned to expand as far as Britain, the money on offer even attracted Russian stars like Ilya Kovalchuk and Alexander Radulov, who walked out on lucrative NHL deals to return home. Then came the crash of the ruble this week. The financial crisis has threatened the plans of players like former Vancouver Canucks goaltender Curtis Sanford, who came to Russia to save for his retirement. "It's just really happened all of a sudden," the 35-year-old Sanford told The Associated Press.
- Russia dismisses new US sanctions as useless
St. Louis Post-Dispatch, Saturday - 12/20/2014 - 05:32 AM
Russia has dismissed new U. S. sanctions as useless and underscored its historic right to the Crimean peninsula.
- FDA OKs Cubist antibiotic for serious infections
Daily Oklahoman, Friday - 12/19/2014 - 08:07 PM
The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May. Zerbaxa is approved to treat bacteria that can cause life-threatening infectious diseases, including food-borne illness due to E. coli. The approval of Zerbaxa on Friday is the second antibiotic approval this year for Cubist Pharmaceuticals, a drugmaker focused on antibiotics.
- Hasbro and Xerox are big market movers
St. Louis Post-Dispatch, Friday - 12/19/2014 - 06:35 PM
Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
- FDA approves AbbVie combo hepatitis C treatment
St. Louis Post-Dispatch, Friday - 12/19/2014 - 03:35 PM
Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie.